The CEO’s Roadmap to the Molecular Future: Strategic Business Insights for the Next Era of Biotech Reagents
Navigating a Maturing Market with Innovation As the molecular biology market matures, business leaders are facing a dual challenge: defending their core PCR business while identifying the "Next Big Thing" in genomics. The days of double-digit growth for basic Taq polymerase are ending in saturated markets, forcing CEOs to look toward "adjacencies" like CRISPR-based diagnostics and synthetic...
0 Comentários 0 Compartilhamentos 15 Visualizações 0 Anterior